These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37407530)

  • 1. [Clinicopathological Features of Primary Small Cell Neuroendocrine Carcinoma of the Bladder].
    Gu YM; Liang XL; Zhang YG; Zhao HY; Jin ML; Li X; Lu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):429-435. PubMed ID: 37407530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroendocrine carcinoma of the urinary bladder:clinicopathologic features analysis of 17 cases].
    Jiang Y; Yu W; Zhang W; Li Y; Lu Q; Liu Y; Li H; Hou F; Li J; Zhuang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):736-41. PubMed ID: 25582251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
    Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
    Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
    Helpap B
    Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Chan E; Garg K; Stohr BA
    Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
    Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
    Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and pathologic characteristics of small cell neuroendocrine carcinoma of urinary tract].
    Guo AT; Chen W; Wei LX
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):747-51. PubMed ID: 23302335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases].
    Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
    Oliva E; Amin MB; Jimenez R; Young RH
    Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
    Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder.
    Paner GP; Annaiah C; Gulmann C; Rao P; Ro JY; Hansel DE; Shen SS; Lopez-Beltran A; Aron M; Luthringer DJ; De Peralta-Venturina M; Cho Y; Amin MB
    Hum Pathol; 2014 Jul; 45(7):1473-82. PubMed ID: 24780825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
    Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelial carcinoma with villoglandular differentiation (UCVGD) with small cell neuroendocrine carcinoma of urinary bladder.
    Jha S; Mitra S; Adhya AK; Nayak P
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30661049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix.
    Zhu R; Wu H; Chen B; Pang J; Huo Z
    Diagn Pathol; 2019 Jun; 14(1):64. PubMed ID: 31228945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell carcinoma of the urinary bladder : Clinicopathologic analysis and oncological outcomes.
    Portugal-Gaspar F; Lopez-Beltran A; Paner GP; Blanca A; Gómez EG; Montironi R; Cimadamore A; Bilé A; Volavšek M; Cheng L
    Virchows Arch; 2024 Sep; 485(3):535-546. PubMed ID: 39023556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin.
    Varinot J; Cussenot O; Roupret M; Conort P; Bitker MO; Chartier-Kastler E; Cheng L; Compérat E
    Virchows Arch; 2013 Dec; 463(6):803-9. PubMed ID: 24146108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.